About Tagestherapiezentrum am ITM Universitätsmedizin Mannheim
Clinical Trials at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim
During the past decade, Tagestherapiezentrum am ITM Universitätsmedizin Mannheim conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim"
#1 collaborator was "Trium Analysis Online GmbH" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "STABIL - Statistische und Biometrische Lösungen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim
According to Clinical.Site data, the most researched conditions in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" are
"Colorectal Cancer" (2 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials), "Adenocarcinoma of the Stomach" (1 trials), "Gastric Adenocarcinoma" (1 trials) and "Metastatic Adenocarcinoma of the Gastroesophageal Junction" (1 trials). Many other conditions were trialed in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" in a lesser frequency.
Clinical Trials Intervention Types at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim
Most popular intervention types in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ramucirumab" (2 trials), "TAS 102" (2 trials), "5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab" (1 trials), "Aflibercept + mLV5FU2" (1 trials) and "Panitumumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim
The vast majority of trials in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" are
5 trials for "All" genders.
Clinical Trials Status at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim
Currently, there are NaN active trials in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Tagestherapiezentrum am ITM Universitätsmedizin Mannheim,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tagestherapiezentrum am ITM Universitätsmedizin Mannheim, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".